| GENERIC NAME | Balaglitazone |
| INDICATION'S | Metabolic Syndrome (Diabetes) |
| MECHANISM OF ACTION | PPAR Gamma Agonist |
| STATUS | Phase II |
| COMPANY | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |